Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0

Abomet 500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Abbott

Salt Composition

Metformin (500mg)

Overview Abomet 500mg Tablet SR

Metformin 500mg Extended-Release tablets manage type 2 diabetes mellitus by regulating blood glucose, mitigating severe diabetic complications. This medication also treats Polycystic Ovary Syndrome (PCOS) in women. For optimal absorption and to prevent stomach upset, consume Metformin 500mg ER tablets with food, consistently at the same time daily. Discontinue use only under physician guidance. Effective diabetes management requires lifestyle changes; adhere to your doctor's dietary and exercise plan. Common side effects include nausea, diarrhea, vomiting, gas, weakness, indigestion, abdominal pain, headache, and decreased appetite. Concurrent use with other diabetes medications, alcohol, or skipped meals may cause hypoglycemia (low blood sugar). Regular blood glucose monitoring is crucial. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your physician. Pregnant or breastfeeding individuals should seek medical advice before use. Kidney function tests will be conducted before initiating therapy. Limit alcohol consumption to reduce the risk of adverse reactions.

Uses of Abomet 500mg Tablet SR

Managing type 2 diabetes and polycystic ovary syndrome (PCOS)

Major Benefits of Abomet 500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the 500mg Abomet SR tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Abomet 500mg Tablet SR:

  • Diarrhea
  • Headache
  • Vomiting
  • Nausea
  • Flatulence
  • Abdominal discomfort
  • Weakness

How to use Abomet 500mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the 500mg Abomet SR tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.

How Abomet 500mg Tablet SR works:

Glucovance 500mg Extended-Release Tablets, a biguanide-class antidiabetic agent, reduces hepatic glucose output, slows intestinal glucose uptake, and enhances insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Abomet 500mg Tablet SR and alcohol is inadvisable due to safety concerns.

PregnancyPregnancySAFE IF PRESCRIBED

The extended-release Abomet 500mg tablet is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no harmful consequences for the fetus; nevertheless, clinical data from human studies are scarce.

Breast feedingBreast feedingCAUTION

Extended-release Abomet 500mg tablets require careful consideration while breastfeeding. Mothers should discontinue breastfeeding throughout their treatment course and until the medication is fully cleared from their system.

DrivingDrivingCAUTION

Operating a vehicle could be impaired by excessively low or high blood glucose levels. Refrain from driving if you experience such symptoms.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Abomet 500mg SR tablets cautiously, potentially requiring a modified dosage. Physician consultation is advised. Abomet 500mg SR tablets are contraindicated in individuals with severely compromised kidney function.

LiverLiverUNSAFE

Extended-release Abomet 500mg tablets are likely unsuitable for individuals with hepatic impairment and should be omitted. Seek medical advice.

What if you forget to take Abomet 500mg Tablet SR :

Should you forget to take a 500mg sustained-release Abomet tablet, ingest it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Abomet 500mg Tablet SR

LabelValue
Type of Compound Biguanide-based medication
Potential for Dependence None.
Medication Classification Medication for diabetes

FAQs on Abomet 500mg Tablet SR

Individuals with type 2 diabetes exhibit impaired responsiveness to their body's own insulin. This leads to elevated blood glucose. Abomet 500mg Tablet SR employs a multifaceted approach to lower these heightened sugar levels. It reduces hepatic glucose production, diminishes intestinal glucose absorption post-prandially, and enhances insulin sensitivity in tissues. Consequently, glucose uptake from the bloodstream is improved, and the body's natural insulin utilization is optimized.
Abomet 500mg sustained-release tablets have demonstrated weight reduction in overweight and obese patients. This weight loss effect may also be observed in overweight or obese individuals with a predisposition to diabetes. Furthermore, individuals with insulin sensitivity or resistance may experience weight loss. However, self-medicating with Abomet for weight management is strongly discouraged; physician consultation is mandatory.
Metformin 500mg extended-release tablets are frequently an initial treatment for hyperglycemia. This medication aids in blood glucose regulation by enhancing the body's insulin sensitivity, reducing hepatic glucose production, and decreasing intestinal glucose absorption. In contrast to other oral hypoglycemics, monotherapy with metformin 500mg extended-release tablets infrequently leads to hypoglycemia because it does not stimulate excessive pancreatic insulin release. Beyond its glycemic control benefits, this medication also assists in managing weight.
Abomet 500mg sustained-release tablets generally do not induce drowsiness and are typically well-received. Infrequently, however, Abomet 500mg sustained-release tablets may lead to sleep disturbances and insomnia. Somnolence can be a symptom of a severe adverse reaction known as lactic acidosis, especially if renal function is compromised. Consult your physician if fatigue or sleepiness develops during Abomet 500mg sustained-release tablet use.
Administer Abomet 500mg sustained-release tablets with or following a meal. Avoid crushing or chewing; ingest whole with water. For once-daily regimens, consume the tablet in the morning with breakfast. If twice-daily dosing is indicated, take one tablet with breakfast and the second with dinner. For thrice-daily prescriptions, distribute the tablets across breakfast, lunch, and dinner. Consuming Abomet 500mg sustained-release tablets with food mitigates potential gastrointestinal discomfort, including indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Individuals with type 2 diabetes either produce insufficient insulin or exhibit impaired responsiveness to endogenous insulin. This leads to elevated blood glucose concentrations. Abomet 500mg Tablet SR employs multiple mechanisms to lower these heightened sugar levels. It reduces hepatic glucose output, diminishes intestinal glucose absorption post-prandially, and enhances insulin sensitivity in bodily tissues and muscles. Consequently, glucose uptake from the bloodstream is improved, and the body's natural insulin response is optimized.
Abomet 500mg sustained-release tablets have demonstrated weight reduction in overweight and obese patients. This weight loss effect may also be observed in overweight and obese individuals predisposed to diabetes. Furthermore, insulin-resistant or insulin-sensitive patients may experience similar results. However, self-initiation of Abomet for weight management is strongly discouraged; physician consultation is mandatory.
Metformin 500mg extended-release tablets are frequently an initial treatment for hyperglycemia. This medication manages blood glucose by enhancing the body's insulin sensitivity, reducing hepatic glucose production, and limiting intestinal glucose absorption. Differing from other oral hypoglycemics, Metformin 500mg extended-release tablets, when used monotherapy, infrequently induce hypoglycemia due to their mechanism that avoids excessive pancreatic insulin release. Beyond glycemic control, this medication also aids in weight management.
Abomet 500mg sustained-release tablets typically don't induce drowsiness and are generally well-received. Infrequently, though, Abomet 500mg sustained-release tablets might lead to sleep disturbances or insomnia. Somnolence can be a symptom of a severe adverse reaction known as lactic acidosis, especially if renal function is impaired. Consult your physician if fatigue or sleepiness develops during Abomet 500mg sustained-release tablet treatment.
Administer Abomet 500mg sustained-release tablets with or following a meal. Avoid crushing or chewing; ingest whole with water. For once-daily regimens, consume the tablet in the morning with breakfast. Twice-daily prescriptions should be divided, one with breakfast and the other with dinner. Three times daily, distribute the doses with breakfast, lunch, and dinner. Consuming Abomet 500mg sustained-release tablets with food mitigates potential gastrointestinal distress including indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Individuals with type 2 diabetes either produce insufficient insulin or exhibit impaired responsiveness to their endogenous insulin. This results in elevated blood glucose concentrations. Abomet 500mg Tablet SR employs a multifaceted approach to lower these elevated blood sugar levels. It reduces hepatic glucose production, diminishes intestinal glucose absorption postprandially, and enhances insulin sensitivity in bodily tissues. This facilitates improved glucose uptake from the bloodstream and optimizes the body's natural insulin response.
Abomet 500mg sustained-release tablets have demonstrated weight reduction in overweight and obese patients. This weight loss effect may also be observed in overweight and obese individuals with pre-diabetes. Furthermore, individuals with insulin sensitivity or resistance may experience weight loss. However, self-medicating with this drug for weight management is strongly discouraged; physician consultation is essential.
Among the initial treatments for elevated blood glucose, Abomet 500mg Tablet SR effectively manages blood sugar. This medication enhances the body's insulin response, reduces hepatic glucose production, and limits intestinal glucose absorption. Differing from other oral antidiabetic agents, solo Abomet 500mg Tablet SR administration infrequently leads to hypoglycemia by preventing excessive pancreatic insulin release. Beyond glycemic control, it also aids in weight management.
Abomet 500mg sustained-release tablets generally do not induce drowsiness and are well-received. Infrequently, though, Abomet 500mg sustained-release tablets may lead to sleep disturbances and insomnia. Drowsiness can be a symptom of a severe adverse reaction known as lactic acidosis, especially if renal function is impaired. Consult your physician immediately if you experience fatigue or somnolence while using Abomet 500mg sustained-release tablets.
Administer Abomet 500mg sustained-release tablets with or following a meal. Avoid crushing or chewing; ingest whole with water. For once-daily prescriptions, morning ingestion with breakfast is recommended. Twice-daily regimens should involve one tablet in the morning and one in the evening, with meals. Three times daily, distribute doses with breakfast, lunch, and dinner. Consuming Abomet 500mg SR with food mitigates potential gastrointestinal distress, including indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Abomet 500mg Tablet SR
26
MRP 35
26% off